S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS)

Authors

Yannis Lafazanos, Advocate Health - MidwestFollow
Eli D. Ehrenpreis, Advocate Health - MidwestFollow

Recommended Citation

Lafazanos Y, Ehrenpreis ED. S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS). American Journal of Gastroenterology. 2024;119(10S):S434-S434. doi:10.14309/01.ajg.0001031876.62582.d1

Affiliations

Advocate Lutheran General

Type

Abstract